The New York Academy of Medicine

CASE
HOMEPAGE

2002 HRSA RWC CONFERENCE

CASE STUDY ABSTRACT, OBJECTIVES & DESIGN

CASE STUDY AMENDMENT: IMPACT OF 9/11 ON PWH/As TAKING HAART

CASE STAFF & GRANTEE ROSTER

DATA COLLECTION TOOLS

CASE STUDY DATA ANALYSIS PLAN

DISSEMINATION ACTIVITIES

RESOURCES & LINKS

  

CASE
The Center for Adherence Support Evaluation
at the New York Academy of Medicine


ABSTRACT INFORMATION AIDS IMPACT 2001
Biopsychosocial Aspects of HIV Infection
Presenting Author 5th International Conference
8-11 July 2001, Brighton, UK
Surname: Mantell, Ph.D.

First name: Joanne

Title: Project Director

Address: Office of Special Populations
New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029

Country: United States

Email: jmantell@nyam.org, jmantell@cnvlz.com

Fax: 212-876-4220 Telephone: 212-822-7238

Option chosen: Option 1

Presentation preference: Oral

Keywords: 4 18 142 35


J. Mantell*, R. Finkelstein*, B. Agins***, R. Alvarez*, B. Arando-Naranjo**, E. Behar*, S. Bowen*, D. Butcher*, T. Cassidy*, R. Cohen**, B. Edlin*, J. Dougherty*, B. Hanna*, L. Hirschorn*, S. Mannheimer*, R. Moore*, L. Mundy*, N. Van Devanter*, M. Waters***, L. Weiss*. *New York Academy of Medicine, CASE, (a cross-site evaluation of 12 adherence support projects), NY; **Health Services & Resources Administration, MD; *** NYS AIDS Institute, NY


ADHERENCE SUPPORT INTERVENTIONS FOR HAART: CRITICAL ISSUES

ISSUES
Inconsistent adherence to highly active antiretroviral therapy (HAART) can lead to medication resistance and transmission of mutant drug-resistant HIV strains. Therefore, helping HIV patients to follow the complex medication regimens demanded by HAART and remain on therapy is an urgent public health priority. In response to the need for rapidly addressing medication difficulties, adherence support programs have been implemented in clinical and community settings, often in the absence of knowing whether the strategy is effective for the target population. Many important questions about the effectiveness of adherence support interventions remain unanswered, including: (1) what intervention models work best with what populations and for how long; (2) what are the intervention dose and threshold levels; (3) what is the constellation of support services; (4) how useful is "readiness"/placebo regimen training; (5) what is the impact of different types of providers; and (6) what is the impact of service delivery system characteristics.
DESCRIPTION
A systematic evaluation of the effectiveness of theory-based adherence support interventions in 12 AIDS centers is underway by the NY Academy of Medicine to determine the type of interventions and care models needed to help people initiate and maintain HAART.
CONCLUSION
Documenting and understanding the salient elements of adherence support interventions will contribute to optimizing the effectiveness of the next generation of programs to help people with HIV to take their medications consistently.

 



CASE
The New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029
(212) 822-7237

Last updated: 4/11/02